Experimental phenylketonuria: metabolic studies in rat liver

Area of Science:

• Biochemistry
• Metabolic pathways
• Enzymology

Background:

• Phenylketonuria (PKU) is a genetic disorder characterized by impaired phenylalanine metabolism.
• Understanding the metabolic consequences of elevated phenylalanine is crucial for managing PKU.
• The liver plays a central role in glucose homeostasis and amino acid metabolism.

Purpose of the Study:

• To investigate the in vivo effects of L-phenylalanine on the gluconeogenic pathway in a rat model of phenylketonuria.
• To examine the impact of L-phenylalanine on the redox state and energy charge of rat liver mitochondria and cytoplasm.
• To determine the effects of phenylalanine and its derivatives on key liver dehydrogenase enzymes.

Main Methods:

• Induction of phenylketonuria-like characteristics in fasted rats.
• Measurement of key gluconeogenic intermediates (fructose 6-phosphate, glucose 6-phosphate, glucose) in liver tissue.
• Analysis of cytoplasmic and mitochondrial NAD+/NADH ratio and energy charge.
• In vitro enzyme assays to determine the inhibitory effects of phenylalanine and its metabolites on lactate dehydrogenase, malate dehydrogenase, and 3-hydroxybutyrate dehydrogenase.

Main Results:

• Significant increases in liver fructose 6-phosphate, glucose 6-phosphate, and glucose concentrations were observed.
• L-phenylalanine administration led to an increased mitochondrial NAD+/NADH ratio with no significant change in energy charge.
• Phenylpyruvate demonstrated significant inhibition of lactate dehydrogenase, mitochondrial and cytoplasmic malate dehydrogenase, and 3-hydroxybutyrate dehydrogenase activities.

Conclusions:

• L-phenylalanine influences gluconeogenesis in the liver of rats with phenylketonuria-like conditions.
• The observed changes in redox state suggest alterations in mitochondrial function.
• Phenylpyruvate and other phenylalanine metabolites act as inhibitors of critical liver dehydrogenases, potentially disrupting metabolic flux.